USPTO serial 79460926
HOPSTEM THERAPEUTICS
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DYER, ERIN ZASKODA
- Law office
- TMEG LAW OFFICE 103
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with HOPSTEM THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cells for medical use; chemical reagents for medical or veterinary purposes; cytostatics for medical purposes; cellular function activating agents for medical purposes; stem cells for medical purposes; living cells for medical use; pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for cell transplantation treatment; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for cellular therapy for the treatment of cancer; pharmaceutical preparations for cellular therapy for the treatment of neurological diseases; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 4, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 3, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 22, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |